Organization · Venture Capital
OphthaFund
OphthaFund is an early-stage investment firm based in the United States, specializing in ophthalmology and life sciences. The organization focuses on identifying and supporting innovative companies in these sectors through strategic investments and extensive due diligence.
Overview
What OphthaFund does
What OphthaFund is
OphthaFund is an early-stage investment firm based in the United States, specializing in ophthalmology and life sciences. The organization focuses on identifying and supporting innovative companies in these sectors through strategic investments and extensive due diligence.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- April 25, 2026
Official channels
Find OphthaFund elsewhere
Open the official website or a supported primary organization account.
Capability profile
OphthaFund as a funder
Investment thesis
OphthaFund specializes in early-stage investments in ophthalmology and life sciences, focusing on companies with strong market potential and clear commercialization pathways. The firm emphasizes rigorous due diligence and strategic guidance to enhance the success of its portfolio companies.
Focus narrative
OphthaFund invests in early-stage companies within the ophthalmology and biotechnology sectors. The organization emphasizes a meticulous approach to due diligence, aiming to identify ventures with strong market potential and clear pathways to commercialization. By leveraging deep domain expertise, the firm seeks to enhance the strategic outcomes of its portfolio companies.
Value beyond capital
OphthaFund adds value to its portfolio companies through extensive research, strategic guidance, and a deep understanding of the ophthalmology and life sciences sectors. The firm leverages its team's expertise in clinical insight and pharma development to enhance company selection and strategic outcomes, ensuring that its investments are well-positioned for success in the market.
Focus and fit
- Stages
- Seed · Series A · Friends and Family · Accelerator
- Sectors
- Biotech · Healthcare · Medical Devices
- Regions
- United StatesNorth America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 6
- Recorded notable exits
- Encore Pharmaceuticals
Portfolio context
OphthaFund's portfolio includes notable investments such as: MCAL Therapeutics: Focused on ophthalmic diseases, this company received seed investment from OphthaFund. Encore Pharmaceuticals: A seed investment that was later acquired by Novartis. ForwardVue Pharma: An ophthalmic therapeutics company that received seed investment. ONL Therapeutics: A company developing therapeutics for retinal diseases, highlighted as a founder-affiliate investment. Premark Pharma: An ophthalmic treatment developer that also received seed investment. Allysta Pharmaceuticals: Engaged in clinical-stage biopharma for rare diseases, with investments across seed, Series A, and Series B stages.
Common questions
What to know about OphthaFund
Upseed classifies OphthaFund under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 25, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.